Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults

被引:25
作者
Ho, RC
Davy, KP
Hickey, MS
Melby, CL
机构
[1] Colorado State Univ, Dept Food Sci & Human Nutr, Nutr & Metab Fitness lab, Ft Collins, CO 80523 USA
[2] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA
关键词
insulin resistance; Mexican Americans; tumor necrosis factor alpha;
D O I
10.1016/j.cyto.2004.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mexican Americans (MA) exhibit high risk for the insulin resistance syndrome characterized by subclinical inflammation and greater risk for type 2 diabetes compared with non-Hispanic white (NHW) adults. The reasons for this phenomenon remain obscure. Because the inflammatory cytokine, tumor necrosis factor-alpha (TNF alpha), is associated with insulin resistance in various models of obesity and diabetes, we sought to determine whether circulating concentrations of this cytokine and its soluble receptors are higher in MA than NHW, and also to determine if the TNF alpha system is related to the lower insulin sensitivity in MA. Fasting blood samples were used to determine concentrations of TNF alpha, soluble TNF receptors 1 (sTNFR1) and 2 (sTNFR2) in the same 13 MA (7 women, 6 men, age=27.0 +/- 2.0 years, BMI=23.0 +/- 0.7) and 13 NHW (7 women. 6 men, age=24.8 +/- 1.5 years. BMI=22.8 +/- 0.6) previously shown to exhibit differences in insulin sensitivity. Circulating TNF alpha was significantly higher (3.11 +/- 0.38 vs. 2.10 +/- 0.24 pg/ml, p < 0.05) and sTNFR2 was significantly lower (1324 +/- 85 vs. 1925 +/- 127 pg/ml, p < 0.05) among MA compared with NHW subjects. Soluble TNFR1 was not different between groups (MA: 970 +/- 111 pg/ml vs. NHW: 1218 +/- 73 pg/ml, p=0.07). TNF alpha, sTNFR1 and sTNFR2 were not correlated with HOMA-IR when the two groups were analyzed in aggregate. This study documents higher circulating TNF alpha concentrations in non-obese, non-diabetic MA, a population group at increased risk for the metabolic syndrome and the untoward effects of sub-clinical inflammation. The clinical implications of this difference, if any, are not yet known. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 59 条
[51]   PATTERN OF SOLUBLE TNF RECEPTOR-I AND RECEPTOR-II IN SEPSIS [J].
SCHRODER, J ;
STUBER, F ;
GALLATI, H ;
SCHADE, FU ;
KREMER, B .
INFECTION, 1995, 23 (03) :143-148
[52]  
STERN MP, 1983, DIABETOLOGIA, V24, P272, DOI 10.1007/BF00282712
[53]   Regulation of insulin action by ceramide - Dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B [J].
Stratford, S ;
Hoehn, KL ;
Liu, F ;
Summers, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) :36608-36615
[54]   ANTIDIABETIC THIAZOLIDINEDIONES BLOCK THE INHIBITORY EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA ON DIFFERENTIATION, INSULIN-STIMULATED GLUCOSE-UPTAKE, AND GENE-EXPRESSION IN 3T3-L1 CELLS [J].
SZALKOWSKI, D ;
WHITECARRINGTON, S ;
BERGER, J ;
ZHANG, B .
ENDOCRINOLOGY, 1995, 136 (04) :1474-1481
[55]   Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity [J].
Uysal, KT ;
Wiesbrock, SM ;
Hotamisligil, GS .
ENDOCRINOLOGY, 1998, 139 (12) :4832-4838
[56]   Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function [J].
Uysal, KT ;
Wiesbrock, SM ;
Marino, MW ;
Hotamisligil, GS .
NATURE, 1997, 389 (6651) :610-614
[57]   Targeted disruption of the tumor necrosis factor-alpha gene - Metabolic consequences in obese and nonobese mice [J].
Ventre, J ;
Doebber, T ;
Wu, M ;
MacNaul, K ;
Stevens, K ;
Pasparakis, M ;
Kollias, G ;
Moller, DE .
DIABETES, 1997, 46 (09) :1526-1531
[58]   Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells [J].
Wallace, FA ;
Neely, SJ ;
Miles, EA ;
Calder, PC .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (01) :40-48
[59]   Elevated serum TNF-α level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients [J].
Winkler, G ;
Lakatos, P ;
Salamon, F ;
Nagy, Z ;
Speer, G ;
Kovács, M ;
Harmos, G ;
Dworak, O ;
Cseh, K .
DIABETIC MEDICINE, 1999, 16 (03) :207-211